Thank you, Madam Chair.
Thank you for all the interesting testimony today. It's very apropos. We just had a neurological disorders subcommittee from 9 a.m. to 11 a.m. and we were talking about some of the challenges we face with ALS.
Could you comment a little bit about the promising current developments in regenerative medicine? I know there was reference to potential treatments. Do you believe we are on the cusp of any breakthroughs--if there was a framework set up that would allow greater research, greater investments?
What are we hoping for? Can you paint a picture for us of what some of the realistic possibilities are?